Refine by
Health Effects Research Articles & Analysis
372 news found
An international survey from Ferring, Fertility Matters at Work and This Can Happen reveals a significant gap exists between employees and employers in recognising the experience of undergoing fertility treatment1 Nearly all employees say fertility treatment impacts their mental health, yet only one third feel supported by their employer’s fertility policies1 Around the world, ...
According to a recent survey by the American Pet Products Association, 82 million households in the United States own a pet. For many, their pet is a part of the family, but unfortunately, many homes with pets also suffer from indoor environmental quality issues associated with pet odors and allergens. Both furry pets and those with feathers can cause an allergic reaction in some people. Pet ...
Alfa Chemistry, a recognized leader in the alkaloid industry, has expanded its offerings to include a comprehensive range of alkaloids-related natural products. This expansion underscores its commitment to providing high-quality compounds for various applications in medicine, food, and cosmetics. The suite of products now includes saccharides, flavonoids, terpenoids, phenylpropanoids, ...
A recent survey found that close to 50% of households in Puerto Rico have at least one pet. For many, their pet is a part of the family, but unfortunately, many homes with pets also suffer from indoor environmental quality (IEQ) issues associated with pet odors and allergens. Both furry pets and those with feathers can cause an allergic reaction in some people. Pet dander is a significant ...
The U.S. Department of Energy announced this week (Jan 24) that it will play a key role in the National Artificial Intelligence Research Resource (NAIRR) pilot as part of President Biden's push to ensure the United States is a leader in harnessing the promise and managing the risks of artificial intelligence (AI). This pilot, led by the U.S. National Science Foundation (NSF), aims to develop a ...
The trial is set to begin in September 2023, and will be available to men with localised intermediate risk prostate cancer who are eligible for radical prostate removal or radiotherapy according to current guidelines. Currently, health insurance companies in the Netherlands do not reimburse for Focal Therapy treatment options (ultrasound ablation (HIFU or TULSA) and irreversible ...
Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces five new hospitals have implemented the Company’s BVA-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023. The addition of these hospitals contributes to the significant growth of blood volume analysis (BVA) ...
Dr. Ali Tinazli is the CEO of lifespin.health and has 15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP). Obesity rates continue to climb alongside a $254.9 billion global weight loss products and services market. Supplements, smartphone weight loss apps, diet plans and exercise programs are widely available to consumers, yet the World Obesity Federation projects that 1 ...
Oligomerix discovers and develops differentiated, oral, small molecule inhibitors of tau self-association that are potentially easy to administer and cost-effective. Oligomerix’s portfolio of compounds is expected to provide a potentially lower-cost treatment alternative or complement the newly emerging high-cost therapeutic options such as monoclonal antibody products. ...
“There is a significant need in the field of neurodegenerative diseases for novel treatment strategies, specifically solutions that are cost-effective and globally scalable,” said Bill Erhardt, M.D., Chief Medical Officer of Oligomerix. ...
A study was conducted in the tau P301L JNPL3 mouse model for tau aggregation and motor impairment that was aged prior to treatment in order to study the therapeutic effect of OLX07010. Statistically significant results showed that treatment prevented further accumulation of tau aggregates and overall levels of tau in the mice over 5 months of treatment administered in the feed ...
Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with Gastro Health, a national leading medical group specializing in digestive and liver health, to bring its AI Recruitment (AIR) technology to Gastro Health’s practices. This strategic partnership will lay the groundwork for future collaborations by using AIR to aid ...
Cellworks Group Inc. a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a study that examined how Differentiation Scoring (DS) derived from key myeloid biomarkers in individual Myelodysplastic Syndrome (MDS) patients using the Cellworks Platform and Computational Biology Model (CBM) can predict response to Hypomethylating Agents (HMA). In ...
“With millions of Americans suffering from Alzheimer’s disease and other neurodegenerative disorders, patients are desperate for safer, accessible and more effective treatment options,” said James Moe, Ph.D., MBA, CEO and Head of Discovery and Strategy at Oligomerix. ...
“This transforms the nature and scope of our understanding of patient outcomes and is critical to rapidly advancing research and care.” Other partners joining xCures in building this relationship with Aetion include AbbVie, Amgen, AstraZeneca, Bayer, Baylor College of Medicine, Brigham and Women’s Hospital and Harvard Medical School, ConcertAI, Duke-Margolis ...
ByxCures
Orginally published by https://www.globenewswire.com/ Emergent BioSolutions Inc. (NYSE:EBS) announced today a research award by the U.S. Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) to evaluate efficacy of the company’s single-dose chikungunya virus virus-like particle (CHIKV VLP) vaccine candidate. Emergent will begin the planning phase, the first ...
BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space. ...
LifeScan, a world leader in blood glucose monitoring, today announced results of a new global research study, conducted by market research firm Burke, Inc., of 793 adults living with Type 2 diabetes and 322 healthcare providers. ...
ByLifeScan
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces Daxor’s BVA-100 diagnostic will be featured in a MedAxiom Academy webinar – Best Practices for Using Blood Volume Analysis to Reduce Heart Failure LOS, Readmissions, Mortality and Costs on November 17, 2022, at 1pm ET. This live webinar will take a deep dive into the best ...
The Series A was co-led by Mubadala Capital and Horizons Ventures, with participation from Bison Ventures, Manta Ray Ventures, IRONGREY, Alumni Ventures, Plum Alley, Jeff Dean (SVP, Google Research and Health), Transform VC, Karl Pfleger, BoxOne Ventures, Intersect VC, Compound, Felicis, and other investors. ...